Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 02 2022
10 02 2022
Historique:
received:
27
07
2021
accepted:
17
01
2022
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
22
2
2022
Statut:
epublish
Résumé
Post-COVID19 complications such as pediatric inflammatory multisystem syndrome (PIMS) and Long-COVID19 move increasingly into focus, potentially causing more harm in young adolescents than the acute infection. To better understand the symptoms of long-term mental health outcomes in adolescents and distinguish infection-associated symptoms from pandemic-associated symptoms, we conducted a 12 question Long-COVID19 survey. Using this survey, we compared the responses on neurocognitive, general pain and mood symptoms from seropositive and seronegative adolescents in a cross-sectional study design. Since May 2020, students grade 8-12 in fourteen secondary schools in Eastern Saxony were enrolled in the SchoolCovid19 study. Serostatus was assessed regularly in all participants. In March/April 2021, 1560 students with a median age of 15 years participated at the regular study visit after re-opening of the schools in mid-March and responded to our Long-COVID19 survey as part of this visit. 1365 (88%) students were seronegative, 188 (12%) were seropositive. Each symptom asked in the Long-COVID19 survey was present in at least 35% of the students within the last seven days before the survey. With the exception of seropositive students being less sad, there was no significant difference comparing the reported symptoms between seropositive students and seronegative students. The lack of differences comparing the reported symptoms between seropositive and seronegative students suggests that Long-COVID19 might be less common than previously thought and emphasizes on the impact of pandemic-associated symptoms regarding the well-being and mental health of young adolescents.Clinical Trial Registration: SchoolCoviDD19: Prospektive Erfassung der SARS-CoV-2 Seropositivität bei Schulkindern nach Ende der unterrichtsfreien Zeit aufgrund der Corona-Schutz-Verordnung (COVID-19), DRKS00022455, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455.
Identifiants
pubmed: 35145161
doi: 10.1038/s41598-022-06166-y
pii: 10.1038/s41598-022-06166-y
pmc: PMC8831534
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2246Subventions
Organisme : Freistaat Sachsen
ID : COVIDD19
Organisme : Freistaat Sachsen
ID : COVIDD19
Informations de copyright
© 2022. The Author(s).
Références
JAMA Pediatr. 2021 Nov 1;175(11):1142-1150
pubmed: 34369987
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Dtsch Arztebl Int. 2020 May 22;117(21):373-374
pubmed: 32519943
Clin Infect Dis. 2020 Dec 3;71(9):2469-2479
pubmed: 32392337
Eur Child Adolesc Psychiatry. 2021 Oct 12;:
pubmed: 34636964
BMJ Paediatr Open. 2021 Mar 24;5(1):e001036
pubmed: 34192197
Lancet Child Adolesc Health. 2021 Feb;5(2):133-141
pubmed: 32956615
JAMA Intern Med. 2014 Mar;174(3):399-407
pubmed: 24276929
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110171
pubmed: 33186638
Acta Paediatr. 2021 Jul;110(7):2208-2211
pubmed: 33835507
BMJ Open. 2021 Jun 10;11(6):e049876
pubmed: 34112645
JAMA. 2021 Jul 15;:
pubmed: 34264266
JAMA. 2021 Mar 16;325(11):1074-1087
pubmed: 33625505
Dtsch Arztebl Int. 2020 Oct 20;117(48):828-829
pubmed: 33568260